Home » Topics » Global Health

Global Health

Global health is an area for study, research, and practice that places a priority on improving health and achieving equity in health for all people worldwide. Greater investment in global health R&D spurs faster medical progress and enables breakthroughs for individual and public health; bolsters U.S. national security; and protects against future public health threats.

“Of all forms of inequality, injustice in health is the most shocking and inhumane.”

– Martin Luther King Jr., Civil Rights Activist & Nobel Prize Recipient

For more information about Research!America’s global health work, contact Victoria Schneider, Senior Manager of Global Health R&D Advocacy.

In the News

COVID clawback in debt limit deal spurs public health fears

Read full article on The Hill. Public health advocacy groups are sounding

 

Events

NIH: The Essentials

We were joined by Dr. Ned Sharpless, who among his many distinctions

 

Events

Alliance Discussion with Dr. Neil Vora, Conservation International

Neil Vora, MD, a physician with Conservation International, joined us to discuss

 

Filter by:

Mary Woolley's Weekly Letter

Leading the Conversation

“Science is a human enterprise. It matters who asks the questions. It matters who interprets the results. It matters who tells the stories.” This powerful statement opens a comment article […]

More: Leading the Conversation

Mary Woolley's Weekly Letter

America Needs Cures, Not Cuts

Women’s Health: The National Academy of Medicine’s (NAM) annual meeting this week featured women’s health topics, “From Cells to Society.” President Biden’s nominee for NIH Director, Monica Bertagnolli, MD (whose […]

More: America Needs Cures, Not Cuts

Mary Woolley's Weekly Letter

What Would Lincoln Do?

Differ We Must: I often quote Abraham Lincoln, “Public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.”  In his new book on Lincoln, “Differ […]

More: What Would Lincoln Do?

Mary Woolley's Weekly Letter

Devil in the Details

Dear Research Advocate, First, some positive news: The 2023 Edelman Trust Barometer, an annual global survey released this week, finds scientists to be trusted by 76% of respondents — slightly […]

More: Devil in the Details

Mary Woolley's Weekly Letter

It’s A Wrap

Dear Research Advocate, Each U.S. consumer is projected to spend a whopping $883 dollars on average on gifts and holiday items this season. That’s more than four times the $215 […]

More: It’s A Wrap

Mary Woolley's Weekly Letter

A Time to Say Thank You

Dear Research Advocate, More than 8 in 10 Americans say they know someone or have themselves experienced at least one brain disorder or mental health condition, according to a national […]

More: A Time to Say Thank You

Mary Woolley's Weekly Letter

Vote! And Keep Engaging

Election day is less than a week away (please be sure to vote!). To better understand what the election means for federally-funded R&D, register to join us for our Post-Election […]

More: Vote! And Keep Engaging

Events

Research!America Alliance Discussion with Dylan George, PhD, Director of Operations for the Center for Forecasting and Outbreak Analytics (CFA), CDC

Join us for an alliance discussion featuring Dr. Dylan George, Director of Operations for the Center for Forecasting and Outbreak Analytics (CFA) at the U.S. Centers for Disease Control and […]

More: Research!America Alliance Discussion with Dylan George, PhD, Director of Operations for the Center for Forecasting and Outbreak Analytics (CFA), CDC

Mary Woolley's Weekly Letter

10 Minutes to Impact

Dear Research Advocate, Members of Congress are back in their home states for August recess, with most focused on the midterm elections. Their Congressional staff members, meanwhile, continue to work […]

More: 10 Minutes to Impact

Resources

Acting Now to Save Lives and Dollars; The National Institute of Allergy and Infectious Diseases Pandemic Preparedness Research Plan (i)

The ongoing COVID-19 pandemic has underscored the need for readily available medical countermeasure platforms to expedite the development of vaccines and therapeutics against emerging infectious diseases (EIDs). Previous responses to […]

More: Acting Now to Save Lives and Dollars; The National Institute of Allergy and Infectious Diseases Pandemic Preparedness Research Plan (i)
Home